PolyProx Therapeutics is a biotechnology company. Founded in 2019, PolyProx Therapeutics is backed by investors that include Cambridge Innovation Capital, Rt Capital Management, and University of Cambridge Enterprise. PolyProx Therapeutics is headquartered in Cambridge.